| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.89▲ | 3.86▲ | 3.87▲ | 3.88▲ | 3.86▲ |
| MA10 | 3.87▲ | 3.85▲ | 3.86▲ | 3.80▲ | 3.95▼ |
| MA20 | 3.86▲ | 3.85▲ | 3.85▲ | 3.81▲ | 3.72▲ |
| MA50 | 3.83▲ | 3.77▲ | 3.75▲ | 3.98▼ | 3.28▲ |
| MA100 | 3.73▲ | 3.77▲ | 3.79▲ | 3.68▲ | 2.93▲ |
| MA200 | 3.77▲ | 3.88▲ | 3.93▼ | 3.25▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.001▲ | 0.001▲ | 0.024▲ | -0.024▼ |
| RSI | 59.490▲ | 58.656▲ | 59.077▲ | 51.801▲ | 57.038▲ |
| STOCH | 80.182▲ | 64.375 | 65.764 | 64.179 | 35.081 |
| WILL %R | -20.000▲ | -20.000▲ | -18.750▲ | -26.866 | -57.463 |
| CCI | 149.686▲ | 229.913▲ | 203.444▲ | 117.274▲ | -33.235 |
|
Tuesday, December 02, 2025 06:14 AM
We are excited to bring the Alpha DaRT technology to prostate cancer patients in the U.S.,” said Dr. Robert B. Den, Alpha Tau Chief Medical Officer. “According to the National Cancer Institute, over ...
|
|
Tuesday, December 02, 2025 04:09 AM
JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that the FDA has ...
|
|
Monday, December 01, 2025 06:05 AM
JERUSALEM, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/12/25 | 3.95 | 3.95 | 3.92 | 3.92 | 28,468 |
| 03/12/25 | 3.86 | 3.885 | 3.78 | 3.88 | 38,995 |
| 02/12/25 | 3.87 | 3.96 | 3.77 | 3.87 | 44,654 |
| 01/12/25 | 3.89 | 4.00 | 3.67 | 3.78 | 48,907 |
| 28/11/25 | 3.79 | 3.995 | 3.77 | 3.97 | 28,153 |
| 26/11/25 | 3.95 | 4.04 | 3.71 | 3.74 | 68,736 |
| 25/11/25 | 3.66 | 4.10 | 3.65 | 3.90 | 102,049 |
| 24/11/25 | 3.85 | 3.85 | 3.65 | 3.65 | 43,298 |
| 21/11/25 | 3.43 | 3.83 | 3.43 | 3.82 | 60,932 |
| 20/11/25 | 3.77 | 3.85 | 3.47 | 3.47 | 80,813 |
|
|
||||
|
|
||||
|
|